• Our Technology
  • EyeSol^®
  • Novel Drug Product Development
  • Chemistry Manufacturing Control (CMC)
• Disease Areas & Pipeline
  • Pipeline
  • Dry Eye Disease
  • Glaucoma
  • Dermatology
  • Diabetic Retinopathy
• Products
  • CyclASol^®
  • NOV03 (perfluorohexyloctane)
  • BTQ 1902
  • Novatears^® (perfluorohexyloctane)
  • Novatears^®+Omega-3
• News & Media
  • Company Presentation
  • Press Releases
  • Publications
• About us
  • Management
  • Supervisory Board
  • Our Partners
• Contact
  • Novaliq in USA
  • Careers
  • Investor Relation